On May 22, 2026, Jin Wan Lin held its annual general meeting and approved the resolution to lift non-compete restrictions for new directors. The authorized directors and their concurrent positions are: Wu Pin-Tsung (Director, Yuan Cui Data Technology), Chen Hui-E (Director, Yuan Cui Data Technology; Independent Director, Beili Biotech Venture Capital), Wu Pin-Hsiang (Director, Yuan Cui Data Technology), Hung Ying-Ju (Director, Yuan Cui Data Technology), Chen Chien-Yu (Head, AEBRLOS GENOMICS INC), and Independent Director Lu Chih-Yi (Director, Prince Pharmaceutical). The waiver is effective for the duration of their tenure as directors of the company. The company stated that these concurrent positions have no material impact on its financial operations.

FACT BOX

  • Source: PR Times
  • Category: Corporate Governance
  • Organizations: AEBRLOS GENOMICS INC